Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept.
D000276:Adjuvants, Immunologic; D000284:Administration, Oral; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage* / Q000378:metabolism; D005776:Gaucher Disease / Q000188:drug therapy*; D005959:Glucosidases / Q000008:administration & dosage*; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy; D014677:Pharmaceutical Vehicles; D010743:Phospholipids / Q000633:toxicity; D001617:beta-Glucosidase / Q000008:administration & dosage* / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D014677:Pharmaceutical Vehicles; D010743:Phospholipids; D003561:Cytarabine; D005959:Glucosidases; D001617:beta-Glucosidase